DRIVIN G ROWTH - Dr. Reddy's

Acknowledgements
The Directors take this opportunity to place on record their sincere thanks to vendors, investors, bankers and auditors for their
continued support.
For and on behalf of the board
Director
Bangalore
April 17, 2002 Director
annexure to the directors report
A] Particulars pursuant to Companies (Disclosure of particulars in the report of the Board of Directors)
1. Conservation of energy
The operations of your Company are not energy intensive. However adequate measures have been taken to reduce energy
consumpton even during the construction period which would have long standing benefits in this area.
2. Research and Development
The business model for Aurgiene is based upon the provision of services in drug discovery to pharmaceutical and biotechnology
companies that wish to accelerate in house discovery programs. Aurigene will enable this by providing services that address
bottlenecks in durg discovery in the post genomic era. During the year has been no costs incurred on account of R&D as it is in
the construction stage.
3. Expenditure in foreign currency on payment basis
Particulars Inrs
Travel 194,282.05
Professional Charges 3,948,240.55
Others 106,120.67
Total 4,248,643.27
AURIGENE DISCOVERY TECHNOLOGIES LTD. | FINANCIALS | ANNUAL REPORT 2001-2002
279